Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jonathan Kaufman

Concepts (276)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intensive Care Units, Pediatric
7
2020
233
1.700
Why?
Cardiac Surgical Procedures
11
2020
531
1.700
Why?
Heart Defects, Congenital
11
2020
832
1.420
Why?
Multiple Myeloma
8
2024
253
1.170
Why?
Hyponatremia
2
2016
42
0.920
Why?
Antineoplastic Combined Chemotherapy Protocols
13
2024
1695
0.900
Why?
Postoperative Complications
9
2020
2641
0.880
Why?
Quality Improvement
3
2018
1161
0.870
Why?
Enteral Nutrition
7
2020
200
0.730
Why?
Intensive Care Units
5
2020
803
0.620
Why?
Airway Extubation
1
2020
57
0.620
Why?
Infant, Newborn
23
2020
6058
0.610
Why?
Vascular Access Devices
1
2018
26
0.570
Why?
Cardiac Care Facilities
1
2017
13
0.570
Why?
Dexamethasone
9
2024
377
0.550
Why?
Postoperative Care
3
2014
258
0.550
Why?
Heart Diseases
3
2016
359
0.530
Why?
Hypernatremia
1
2016
8
0.530
Why?
Hypoplastic Left Heart Syndrome
2
2014
121
0.490
Why?
Vasodilator Agents
3
2013
333
0.490
Why?
Stem Cell Transplantation
2
2022
177
0.480
Why?
Boronic Acids
3
2014
38
0.460
Why?
Tachycardia
2
2014
58
0.450
Why?
Infant
18
2020
9464
0.440
Why?
Unnecessary Procedures
1
2014
49
0.440
Why?
Blood Chemical Analysis
1
2014
98
0.440
Why?
Pyrazines
3
2014
92
0.430
Why?
Infant, Premature
3
2020
568
0.430
Why?
Parenteral Nutrition
1
2015
107
0.430
Why?
Milrinone
1
2013
29
0.420
Why?
Norwood Procedures
1
2013
29
0.420
Why?
Calcitonin
1
2013
27
0.420
Why?
Cardiovascular Surgical Procedures
1
2013
30
0.420
Why?
Prilocaine
1
2013
4
0.410
Why?
Methemoglobinemia
1
2013
13
0.410
Why?
Lidocaine
1
2013
42
0.400
Why?
Tidal Volume
1
2013
86
0.400
Why?
Protein Precursors
1
2013
132
0.390
Why?
Anesthetics, Local
1
2013
80
0.390
Why?
Masks
1
2013
62
0.390
Why?
Critical Illness
2
2016
808
0.390
Why?
Thrombosis
2
2018
368
0.380
Why?
Nutritional Status
1
2015
344
0.380
Why?
Bronchiolitis
1
2013
91
0.380
Why?
Continuous Positive Airway Pressure
1
2013
82
0.380
Why?
Cardiac Output, Low
1
2012
66
0.370
Why?
Cardiotonic Agents
1
2012
126
0.360
Why?
Catheter Obstruction
1
2011
4
0.360
Why?
Weight Gain
1
2015
518
0.360
Why?
C-Reactive Protein
1
2013
411
0.350
Why?
Chylothorax
1
2010
16
0.350
Why?
Octreotide
1
2010
26
0.350
Why?
Length of Stay
6
2018
1210
0.340
Why?
Thoracic Surgical Procedures
1
2010
73
0.320
Why?
Heart Rate
1
2013
831
0.320
Why?
Retrospective Studies
17
2020
15628
0.310
Why?
Catheterization, Central Venous
1
2011
111
0.310
Why?
Heparin
1
2011
259
0.310
Why?
Seizures
1
2013
431
0.310
Why?
Bortezomib
7
2024
54
0.310
Why?
Abnormalities, Multiple
1
2011
189
0.310
Why?
Gastrostomy
2
2020
113
0.310
Why?
Extracorporeal Membrane Oxygenation
2
2012
292
0.310
Why?
Antibodies, Monoclonal, Murine-Derived
5
2013
88
0.300
Why?
Lymphoma, Non-Hodgkin
3
2015
88
0.290
Why?
Vasculitis
1
2008
65
0.290
Why?
Palliative Care
1
2015
737
0.290
Why?
Humans
48
2024
137509
0.290
Why?
Male
35
2024
67715
0.280
Why?
Sepsis
1
2013
611
0.270
Why?
Colorado
5
2020
4521
0.260
Why?
Female
33
2024
73160
0.250
Why?
Antibodies, Monoclonal
4
2024
1428
0.250
Why?
Critical Care
1
2011
583
0.250
Why?
Respiration, Artificial
3
2020
643
0.240
Why?
Incidence
5
2020
2791
0.220
Why?
Enterocolitis, Necrotizing
2
2018
38
0.210
Why?
Intubation, Intratracheal
2
2020
259
0.210
Why?
Biomarkers
3
2016
4172
0.210
Why?
Rhabdomyosarcoma
1
2024
72
0.210
Why?
Follow-Up Studies
7
2020
5138
0.210
Why?
Intubation, Gastrointestinal
2
2020
77
0.210
Why?
Child, Preschool
12
2019
11094
0.200
Why?
Prospective Studies
7
2018
7598
0.200
Why?
Maintenance Chemotherapy
1
2022
35
0.190
Why?
Cohort Studies
5
2019
5728
0.190
Why?
Child
12
2024
22034
0.190
Why?
Time Factors
8
2017
6817
0.190
Why?
Acute Kidney Injury
4
2020
811
0.190
Why?
Disease-Free Survival
5
2022
690
0.190
Why?
Cyclophosphamide
5
2020
251
0.190
Why?
Rituximab
6
2015
178
0.180
Why?
Drug Administration Schedule
6
2014
784
0.180
Why?
Cyanosis
1
2020
16
0.170
Why?
Risk Factors
8
2020
10355
0.170
Why?
Immunoglobulin Light-chain Amyloidosis
1
2020
7
0.170
Why?
Fundoplication
1
2020
54
0.170
Why?
Analysis of Variance
2
2013
1324
0.170
Why?
Smoldering Multiple Myeloma
1
2019
7
0.160
Why?
Clinical Trials as Topic
1
2024
1047
0.160
Why?
Calcaneus
1
2019
31
0.160
Why?
Lymphoma, B-Cell
2
2012
107
0.150
Why?
Ketorolac
1
2018
20
0.150
Why?
Treatment Outcome
10
2020
10821
0.150
Why?
Platelet Aggregation
1
2018
100
0.150
Why?
Gastroesophageal Reflux
1
2020
235
0.140
Why?
Catheters, Indwelling
1
2018
83
0.140
Why?
Urine Specimen Collection
1
2017
2
0.140
Why?
Combined Modality Therapy
2
2010
1241
0.140
Why?
Morphine
1
2018
160
0.130
Why?
Dose-Response Relationship, Drug
4
2014
2066
0.130
Why?
Diuretics
1
2016
74
0.130
Why?
Spectroscopy, Near-Infrared
1
2016
56
0.120
Why?
Lymphoma, Follicular
2
2015
40
0.120
Why?
Sodium
1
2016
218
0.120
Why?
Pain, Postoperative
1
2018
272
0.120
Why?
Bone Density
1
2019
486
0.120
Why?
Urinary Tract Infections
1
2017
167
0.120
Why?
Prognosis
5
2018
4030
0.120
Why?
Logistic Models
4
2014
2064
0.120
Why?
Quality of Life
2
2024
2869
0.110
Why?
Thalidomide
2
2015
40
0.110
Why?
Gestational Age
2
2020
903
0.110
Why?
Transplantation, Autologous
3
2022
238
0.110
Why?
Hypertension, Pulmonary
1
2005
1903
0.110
Why?
Aged
11
2024
23795
0.110
Why?
Heart
1
2018
660
0.110
Why?
Remission Induction
2
2014
287
0.110
Why?
Calcitonin Gene-Related Peptide
1
2013
40
0.100
Why?
Port-Wine Stain
1
2013
2
0.100
Why?
Delivery Rooms
1
2013
7
0.100
Why?
Liver Function Tests
1
2013
114
0.100
Why?
Antibodies, Monoclonal, Humanized
2
2022
807
0.100
Why?
Pediatrics
2
2011
1123
0.100
Why?
Administration, Topical
1
2013
149
0.100
Why?
Equipment Failure
1
2013
108
0.100
Why?
Lung
1
2005
4066
0.100
Why?
Intubation
1
2012
3
0.100
Why?
Statistics, Nonparametric
1
2013
434
0.100
Why?
Health Care Surveys
2
2011
567
0.100
Why?
Respiration
1
2013
198
0.100
Why?
Pentobarbital
1
2011
16
0.090
Why?
Australia
1
2013
314
0.090
Why?
Survival Rate
2
2013
1979
0.090
Why?
Patient Admission
1
2013
191
0.090
Why?
Adult
12
2024
37818
0.090
Why?
Vein of Galen Malformations
1
2011
2
0.090
Why?
Down Syndrome
1
2018
492
0.090
Why?
Hematopoietic Stem Cell Mobilization
1
2011
22
0.090
Why?
Status Epilepticus
1
2011
50
0.090
Why?
Peripheral Blood Stem Cell Transplantation
1
2011
24
0.090
Why?
Heterocyclic Compounds
1
2011
20
0.090
Why?
Middle Aged
11
2024
33353
0.090
Why?
Airway Obstruction
1
2013
162
0.090
Why?
Professional Practice
1
2011
64
0.090
Why?
Respiratory Function Tests
1
2013
596
0.090
Why?
Receptors, CXCR4
1
2011
85
0.090
Why?
Linear Models
1
2013
850
0.090
Why?
Intracranial Arteriovenous Malformations
1
2011
50
0.090
Why?
Chemoprevention
1
2011
93
0.090
Why?
Nutritional Support
1
2010
34
0.090
Why?
Anesthetics, Intravenous
1
2010
47
0.090
Why?
Ventilator Weaning
1
2010
36
0.090
Why?
Diet, Fat-Restricted
1
2010
79
0.080
Why?
Electrocardiography
1
2013
632
0.080
Why?
ROC Curve
1
2012
547
0.080
Why?
Fatal Outcome
1
2011
305
0.080
Why?
Salvage Therapy
1
2011
143
0.080
Why?
Aortic Coarctation
1
2011
83
0.080
Why?
Propofol
1
2010
73
0.080
Why?
Infusions, Intravenous
3
2018
411
0.080
Why?
Analgesics, Opioid
1
2018
1002
0.080
Why?
Drainage
1
2010
169
0.080
Why?
Kinetics
1
2013
1679
0.080
Why?
Molecular Targeted Therapy
1
2013
414
0.080
Why?
Lymphoma
1
2011
206
0.080
Why?
Hypnotics and Sedatives
1
2011
199
0.080
Why?
Maximum Tolerated Dose
3
2015
199
0.080
Why?
Birth Weight
1
2013
516
0.080
Why?
Device Removal
1
2010
138
0.080
Why?
Plasmapheresis
1
2008
24
0.080
Why?
Alprostadil
1
2008
32
0.080
Why?
High-Frequency Ventilation
1
2008
45
0.080
Why?
Diagnosis, Differential
1
2013
1486
0.070
Why?
Vincristine
3
2015
116
0.070
Why?
Renal Replacement Therapy
1
2008
92
0.070
Why?
Kidney
1
2016
1472
0.070
Why?
Neoplasm Recurrence, Local
1
2014
1060
0.070
Why?
Neoadjuvant Therapy
1
2010
405
0.070
Why?
Kaplan-Meier Estimate
3
2015
892
0.070
Why?
Adolescent
8
2018
21552
0.070
Why?
Doxorubicin
3
2015
368
0.070
Why?
Predictive Value of Tests
1
2012
2039
0.060
Why?
Patient Readmission
1
2012
696
0.060
Why?
Immunologic Factors
1
2008
239
0.060
Why?
Preoperative Care
1
2008
356
0.060
Why?
Interleukin-6
1
2010
778
0.060
Why?
Anticoagulants
1
2011
664
0.060
Why?
Interferons
1
2007
199
0.060
Why?
rho-Associated Kinases
1
2005
85
0.060
Why?
Adrenal Cortex Hormones
1
2008
555
0.060
Why?
HIV Infections
1
2019
2830
0.060
Why?
Hemorrhage
1
2008
723
0.050
Why?
Antineoplastic Agents
2
2022
2145
0.050
Why?
Immunosuppressive Agents
1
2008
891
0.050
Why?
Attitude of Health Personnel
1
2011
1168
0.050
Why?
Prednisone
2
2015
245
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2005
455
0.050
Why?
Autografts
1
2022
45
0.050
Why?
Melphalan
1
2022
35
0.050
Why?
Thrombocytopenia
2
2015
199
0.050
Why?
Pneumonia
2
2020
638
0.050
Why?
Lung Diseases
1
2008
768
0.050
Why?
Case-Control Studies
2
2019
3546
0.040
Why?
Recurrence
2
2015
1060
0.040
Why?
Severity of Illness Index
1
2008
2838
0.040
Why?
Viscera
1
2020
17
0.040
Why?
Immunoglobulin Light Chains
1
2020
47
0.040
Why?
Cellulitis
1
2020
54
0.040
Why?
Immunoglobulin Heavy Chains
1
2020
83
0.040
Why?
Nervous System
1
2020
69
0.040
Why?
South Africa
1
2019
219
0.040
Why?
Heart Failure
1
2012
2222
0.040
Why?
Cardiopulmonary Bypass
1
2020
209
0.040
Why?
Aged, 80 and over
2
2020
7591
0.040
Why?
Postoperative Period
1
2018
344
0.030
Why?
Thrombelastography
1
2018
153
0.030
Why?
Anti-Retroviral Agents
1
2019
235
0.030
Why?
Infant Mortality
1
2018
115
0.030
Why?
Rats
1
2005
5676
0.030
Why?
Specimen Handling
1
2017
178
0.030
Why?
Comorbidity
1
2020
1618
0.030
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2018
350
0.030
Why?
Ultrasonography
1
2019
750
0.030
Why?
Disease Progression
1
2022
2756
0.030
Why?
Peripheral Nervous System Diseases
1
2015
129
0.030
Why?
Hydroxamic Acids
1
2014
89
0.030
Why?
Oligopeptides
1
2015
273
0.030
Why?
Hyperbilirubinemia
1
2013
13
0.030
Why?
Gastrointestinal Diseases
1
2015
210
0.030
Why?
Pulmonary Embolism
1
2015
222
0.030
Why?
Liver Failure
1
2013
94
0.020
Why?
Neutropenia
1
2013
146
0.020
Why?
Administration, Oral
1
2014
814
0.020
Why?
Longitudinal Studies
1
2019
2857
0.020
Why?
Chemical Fractionation
1
2011
29
0.020
Why?
Ventricular Function, Right
1
2014
283
0.020
Why?
Neural Conduction
1
2012
86
0.020
Why?
Cytarabine
1
2011
61
0.020
Why?
Neurologic Examination
1
2011
113
0.020
Why?
Multiple Organ Failure
1
2012
127
0.020
Why?
Benzylamines
1
2011
41
0.020
Why?
Prostaglandins
1
2011
97
0.020
Why?
Indoles
1
2014
415
0.020
Why?
Survival Analysis
1
2014
1320
0.020
Why?
Antigens, CD34
1
2011
88
0.020
Why?
Mouth
1
2011
86
0.020
Why?
Granulocyte Colony-Stimulating Factor
1
2011
74
0.020
Why?
Blood Component Removal
1
2011
26
0.020
Why?
Risk Assessment
1
2020
3439
0.020
Why?
Internationality
1
2011
155
0.020
Why?
Liver Cirrhosis
1
2013
316
0.020
Why?
Double-Blind Method
1
2014
1987
0.020
Why?
Electroencephalography
1
2011
438
0.020
Why?
Cost-Benefit Analysis
1
2011
591
0.020
Why?
Hematopoietic Stem Cells
1
2011
398
0.020
Why?
Hospital Mortality
1
2012
902
0.020
Why?
Animals
2
2010
37009
0.020
Why?
Internet
1
2011
656
0.020
Why?
Young Adult
2
2011
13241
0.010
Why?
Liver
1
2013
1940
0.010
Why?
Immunotherapy
1
2007
647
0.010
Why?
Randomized Controlled Trials as Topic
1
2007
1465
0.010
Why?
Mice, Inbred C57BL
1
2010
5792
0.010
Why?
United States
1
2011
14695
0.010
Why?
Mice
1
2010
17843
0.010
Why?
Kaufman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)